23 May 2013
Keywords: fda, approves, sanofi, skelid, received, clearance, food
Article | 17 March 1997
- Sanofi has received clearance from the US Food and Drug Administrationto market Skelid (tiludronate disodium), its oral bisphosphonate
treatment for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 March 1997
© 2013 thepharmaletter.com